Use of lipoprotein(a) for refining cardiovascular risk prediction in a low-risk population: The CoLaus/PsyCoLaus study

Eur J Prev Cardiol. 2021 Jul 23;28(8):e18-e20. doi: 10.1177/2047487320938271. Epub 2020 Jul 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiovascular Diseases* / diagnosis
  • Cardiovascular Diseases* / epidemiology
  • Heart Disease Risk Factors
  • Humans
  • Lipoprotein(a)*
  • Risk Factors
  • Switzerland

Substances

  • Lipoprotein(a)